<DOC>
	<DOCNO>NCT00370266</DOCNO>
	<brief_summary>The purpose study determine whether intraocular injection triamcinolone effective treatment macular edema acute branch retinal vein occlusion .</brief_summary>
	<brief_title>Intravitreal Triamcinolone Acute Branch Retinal Vein Occlusion</brief_title>
	<detailed_description>Intravitreal triamcinolone recently show beneficial effect chronic macular edema due vein occlusion preventive effect neovascularization . Hypothetically , prevention macular derangement reduce amount edema early phase occlusion restoration collateral seem helpful eye . To knowledge , prospective randomize clinical trial , consider macular change preventive effect neovascularization publish intravitreal triamcinolone acute branch retinal vein occlusion .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Eyes suffer branch retinal vein occlusion le 2 month duration . Monocularity , Previous intraocular surgery laser therapy Glaucoma ocular hypertension Significant medium opacity Existence traction macula Visual acuity â‰¥20/40 Signs chronicity ( cilioretinal and/or retinal shunt vessel )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Macular edema</keyword>
	<keyword>Branch retinal vein occlusion</keyword>
	<keyword>Intravitreal triamcinolone</keyword>
	<keyword>Macular thickness</keyword>
	<keyword>Retinal neovascularization</keyword>
</DOC>